Skip to main content
NEJM Catalyst homepage

Concerns about Patient Access to Biopharmaceuticals and Outcomes

Published January 18, 2023
NEJM Catal Innov Care Deliv 2023;4(2)
DOI: 10.1056/CAT.23.0011

Summary

A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices.

Notes

Amitabh Chandra and Jay Patel have nothing to disclose.

Information & Authors

Information

Published In

NEJM Catalyst Innovations in Care Delivery

History

Published online: January 18, 2023
Published in issue: January 18, 2023

Topics

Authors

Affiliations

Amitabh Chandra, PhD
Ethel Zimmerman Wiener Professor of Public Policy and Director, Health Policy Research, Harvard Kennedy School, Cambridge, Massachusetts, USA; Henry and Allison McCance Professor of Business Administration, Harvard Business School, Cambridge, Massachusetts, USA
Jay V. Patel, PharmD, MBA
Vice President, Pharmacy Growth and Product Development, Humana, Boston, Massachusetts, USA

Metrics & Citations

Metrics

Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

View Options

View options

PDF

View PDF

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

CONTENT LINK

Share

Innovation Cover - Mobile
Innovation Cover - Tablet Innovation Cover - Desktop

Fostering an Innovation Culture
to Reimagine Care Delivery

A collection of forward-thinking articles from NEJM Catalyst on innovative approaches to the biggest problems facing health care.